Pfizer Wins Another Battle In Norvasc War
Two weeks after a jury ruled unanimously in its favor, Pfizer Inc. has chalked up another victory in its crusade to protect its blockbuster blood pressure medication, Norvasc, from a generic...To view the full article, register now.
Already a subscriber? Click here to view full article